HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VU0467485

M4R positive allosteric modulator

Also Known As:

AZ13713945

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridazines: 11
    - VU0467485: 1

Experts

1.	Blobaum, Anna L: 1 article (02/2017)
2.	Brandon, Nicholas J: 1 article (02/2017)
3.	Bridges, Thomas M: 1 article (02/2017)
4.	Bubser, Michael: 1 article (02/2017)
5.	Chang, Sichen: 1 article (02/2017)
6.	Conn, P Jeffrey: 1 article (02/2017)
7.	Duggan, Mark E: 1 article (02/2017)
8.	Engers, Darren W: 1 article (02/2017)
9.	Hurtado, Miguel A: 1 article (02/2017)
10.	Jones, Carrie K: 1 article (02/2017)

Related Diseases

1.	Schizophrenia (Dementia Praecox) 02/09/2017 - "Compound 6c (VU0467485) possesses robust in vitro M4 PAM potency across species and in vivo efficacy in preclinical models of schizophrenia. " 02/09/2017 - "Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia."

Related Drugs and Biologics

1.	VU0467485